This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

Jazz Pharmaceuticals – Third Quarter 2023 Financial Results

09 November 2023

Hamilton, Bermuda:  9 November 2023 – In a filing with the Bermuda Stock Exchange, Jazz Pharmaceuticals announces Third Quarter 2023 Financial Results. Click the link to view the full filing:


2023 Q3 Interim Statement



2023 Q3 Financial Report 10-Q




# # # #


About BSX

The Bermuda Stock Exchange (BSX) is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit or contact



Disclaimer and Privacy Policy    Complaints Policy

Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!

Questions or requests for information can be emailed to